Literature DB >> 8530415

Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors.

M Nakamura1, C Sakanaka, Y Aoki, H Ogasawara, T Tsuji, H Kodama, T Matsumoto, T Shimizu, M Noma.   

Abstract

Two cDNA clones homologous with human neuropeptide (NP) Y-Y1 receptor have been isolated from a mouse bone marrow cDNA library. One was thought to be the cognate of the human NPY-Y1 receptor, termed Y1 alpha receptor, and the other form, termed Y1 beta receptor, differed from the Y1 alpha receptor in the seventh transmembrane domain and C-terminal tail. Analysis of the mouse genomic DNA showed that both receptors originated from a single gene. The different peptide sequences of the Y1 beta receptor were encoded by separate exons, hence, these receptors were generated by differential RNA splicing. High affinity binding of [125I]NPY to each receptor expressed in Chinese hamster ovary (CHO) cells and sequestration of [125I]NPY after binding to each receptor were observed. In the CHO cells expressing the Y1 alpha receptor, intracellular Ca2+ increase, inhibition of forskolin-induced cAMP accumulation, and mitogen-activated protein kinase (MAPK) activation were observed by stimulation of NPY, and these responses were abolished by pretreatment with pertussis toxin. Since wortmannin completely inhibited NPY-elicited MAPK activation, we speculate that wortmannin-sensitive signaling molecule(s) such as phosphoinositide 3-kinase may lie between pertussis toxin-sensitive G-protein and MAPK. In contrast, these intracellular signals were not detected in CHO cells expressing the Y1 beta receptor. Northern blots and reverse transcriptase-polymerase chain reaction analyses indicated that the Y1 alpha receptor was highly expressed in the brain, heart, kidney, spleen, skeletal muscle, and lung, whereas the Y1 beta receptor mRNA was not detected in these tissues. However, the Y1 beta receptor was expressed in mouse embryonic developmental stage (7 and 11 days), bone marrow cells and several hematopoietic cell lines. These results suggest that the Y1 beta receptor is an embryonic and a bone marrow form of the NPY-Y1 receptor, which decreases in the expression during development and differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530415     DOI: 10.1074/jbc.270.50.30102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.

Authors:  A Kushi; H Sasai; H Koizumi; N Takeda; M Yokoyama; M Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons.

Authors:  G Chen; A N van den Pol
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  Differential pre- and postsynaptic modulation of chemical transmission in the squid giant synapse by tyrosine phosphorylation.

Authors:  R Llinás; H Moreno; M Sugimori; M Mohammadi; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 4.  The NPY system and its neural and neuroendocrine regulation of bone.

Authors:  Ee Cheng Khor; Paul Baldock
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 5.  Signaling from novel splice variants of hormone receptors in cancer.

Authors:  Wei-Qun Ding; Laurence J Miller
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors.

Authors:  F Cogé; S P Guenin; A Renouard-Try; H Rique; C Ouvry; N Fabry; P Beauverger; J P Nicolas; J P Galizzi; J A Boutin; E Canet
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

7.  The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.

Authors:  Yih-Shou Hsieh; Meng-Hsien Kuo; Pei-Ni Chen; Dong-Yih Kuo
Journal:  Neuromolecular Med       Date:  2012-11-20       Impact factor: 3.843

8.  Bone-specific overexpression of NPY modulates osteogenesis.

Authors:  I Matic; B G Matthews; T Kizivat; J C Igwe; I Marijanovic; S T Ruohonen; E Savontaus; D J Adams; I Kalajzic
Journal:  J Musculoskelet Neuronal Interact       Date:  2012-12       Impact factor: 2.041

9.  Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization.

Authors:  R M Lyu; P M Germano; J K Choi; S V Le; J R Pisegna
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

10.  Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors.

Authors:  Kazunori Kawamura; Wakana Mori; Masayuki Fujinaga; Tomoteru Yamasaki; Yiding Zhang; Hidekatsu Wakizaka; Akiko Hatori; Lin Xie; Katsushi Kumata; Takayuki Ohkubo; Yusuke Kurihara; Masanao Ogawa; Nobuki Nengaki; Ming-Rong Zhang
Journal:  EJNMMI Radiopharm Chem       Date:  2019-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.